Enzymatica AB (publ) (STO:ENZY)
1.880
+0.015 (0.80%)
Jul 24, 2026, 4:27 PM CET
Enzymatica AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 13.15 | 33.13 | 75.21 | 8.37 | 50.69 | 31.62 |
Cash & Short-Term Investments | 13.15 | 33.13 | 75.21 | 8.37 | 50.69 | 31.62 |
Cash Growth | -70.97% | -55.95% | 799.02% | -83.49% | 60.31% | 31.65% |
Accounts Receivable | 4.35 | 10 | 12.09 | 11.34 | 14.23 | 16.32 |
Other Receivables | 4.48 | 2.98 | 7.99 | 7.57 | 2.29 | 2.51 |
Total Trade Receivables | 8.83 | 12.98 | 20.08 | 18.92 | 16.52 | 18.83 |
Inventory | 14.47 | 18.92 | 16.71 | 11.5 | 11.51 | 12.44 |
Other Current Assets | - | - | - | - | 6.13 | 1.89 |
Total Current Assets | 36.44 | 65.03 | 112 | 38.78 | 84.85 | 64.78 |
Net Property, Plant & Equipment | 22.94 | 10.37 | 14.4 | 16.48 | 16.4 | 15.16 |
Other Intangible Assets | 63.18 | 64.18 | 66.19 | 68.33 | 70.85 | 74.98 |
Other Long-Term Assets | 2.06 | 2.41 | 2.64 | 2.32 | - | - |
Total Assets | 124.63 | 141.98 | 195.22 | 125.91 | 174.41 | 157.04 |
Accounts Payable | 1.9 | 8.75 | 9.81 | 7.37 | 6.67 | 7.61 |
Accrued Expenses | - | - | - | - | 17.96 | 20.02 |
Short-Term Debt | 2.65 | 1.02 | 1.18 | 1.22 | 1.2 | 1.51 |
Other Current Liabilities | 10.35 | 8.03 | 6.84 | 15.83 | 1.18 | 1.8 |
Total Current Liabilities | 14.9 | 17.8 | 17.83 | 24.42 | 27 | 30.94 |
Long-Term Debt | 11.52 | 0.01 | 1.02 | 24.88 | - | - |
Other Long-Term Liabilities | - | - | - | - | 21.12 | 1.12 |
Total Long-Term Liabilities | 11.52 | 0.01 | 1.02 | 24.88 | 21.12 | 1.12 |
Total Liabilities | 26.42 | 17.81 | 18.86 | 49.3 | 48.12 | 32.07 |
Common Stock | - | - | - | - | 6.57 | 5.97 |
Additional Paid-in Capital | - | - | - | - | 507.2 | 438.83 |
Accumulated Other Comprehensive Income | - | - | - | - | 0.17 | -0.85 |
Retained Earnings | - | - | - | - | -387.64 | -318.99 |
Total Common Shareholders' Equity | - | - | - | - | 126.29 | 124.97 |
Shareholders' Equity | 98.22 | 124.17 | 176.37 | 76.61 | 126.29 | 124.97 |
Total Liabilities & Equity | 124.63 | 141.98 | 195.22 | 125.91 | 174.41 | 157.04 |
Total Debt | 14.17 | 1.02 | 2.2 | 26.1 | 1.2 | 1.51 |
Net Cash (Debt) | -1.02 | 32.11 | 73.01 | -17.74 | 49.49 | 30.11 |
Net Cash Growth | - | -56.02% | - | - | 64.38% | 167.61% |
Net Cash Per Share | -0.00 | 0.13 | 0.38 | -0.11 | 0.32 | 0.20 |
Book Value | - | 0 | 0 | 0 | 126.29 | 124.97 |
Book Value Per Share | - | - | - | - | 0.82 | 0.85 |
Tangible Book Value | -63.18 | -64.18 | -66.19 | -68.33 | 55.45 | 49.99 |
Tangible Book Value Per Share | -0.26 | -0.26 | -0.34 | -0.42 | 0.36 | 0.34 |